Mal-PEG2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-acid can be conjugated to Tubulysin (HY-128914) and its derivative cytotoxic molecule.
Structure of 1374666-32-6
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Mal-PEG2-acid, a versatile bifunctional polyethylene glycol derivative, finds extensive utility in diverse biochemical and pharmaceutical realms. Here are four key applications of Mal-PEG2-acid:
Protein Modification: Widely employed for protein modification, Mal-PEG2-acid facilitates pegylation to enhance the stability and solubility of proteins. Molecularly linking polyethylene glycol chains can extend the circulating half-life of therapeutic proteins by diminishing their immunogenicity and susceptibility to proteolytic degradation. Consequently, pegylated proteins often exhibit heightened therapeutic efficacy and improved patient compliance.
Drug Delivery Systems: In the realm of pharmaceutical research, Mal-PEG2-acid plays a pivotal role in tailoring drug delivery systems to modulate the pharmacokinetics of active compounds. Through the attachment of polyethylene glycol chains, drugs can be shielded from the immune system, enhancing their bioavailability and mitigating adverse effects. This strategy proves particularly beneficial for the targeted delivery of small molecules, peptides, and nucleic acids to designated sites.
Bioconjugation: Serving as a versatile linker for bioconjugation reactions, Mal-PEG2-acid enables the attachment of biomolecules or functional groups. Its maleimide group selectively reacts with thiol groups, such as those in cysteine residues, facilitating the formation of stable thioether bonds. This methodology sees widespread use in crafting antibody-drug conjugates, nanocarriers, and multifunctional biomaterials, underscoring its significance in bioconjugation chemistry.
Surface Modification: Within the domain of materials science, Mal-PEG2-acid is instrumental in the surface modification of nanoparticles, hydrogels, and other biomaterials to bolster biocompatibility and diminish nonspecific interactions. PEGylated surfaces effectively deter protein adsorption and cell adhesion, rendering them optimal for biomedical implants and diagnostic assays. This ensures the seamless integration of devices into biological systems with minimal immune reactivity, underscoring the importance of surface modification techniques.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00442 | Mal-PEG6-NHS | 1137109-21-7 | |
BADC-00448 | Mal-PEG-NHS | 1260092-50-9 | |
BADC-00443 | Mal-PEG5-NHS | 1315355-92-0 | |
BADC-00450 | Mal-PEG4-NHS | 1325208-25-0 | |
BADC-01679 | Mal-PEG2-Val-Cit-PABA-PNP | 1345681-52-8 | |
BADC-00449 | Mal-PEG4-PFP | 1415800-42-8 | |
BADC-00453 | Mal-PEG2-NHS ester | 1433997-01-3 | |
BADC-00603 | Mal-PEG3-NHS ester | 1537892-36-6 | |
BADC-00966 | Mal-PEG4-VC-PAB-DMEA | 1569261-93-3 | |
BADC-00499 | Mal-PEG6-NHS ester | 1599472-25-9 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.